Einhorn's Greenlight Capital Losses 4% in Q2 as Bubble Basket Proves 'Frustrating'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Amazon.com (AMZN) Prime Day Penetration Not as Great as Expected -FBR Capital
July 18, 2017 7:32 AM EDTFBR Capital analyst Susan Anderson offers insight on Amazon.com (NASDAQ: AMZN) Prime Day penetration following surveys to assess purchasing trends and habits of prime customers on July 11th.
Anderson notes surprising data, suggesting only 21% of survery respondents made purchases on Prime... More
Mallinckrodt (MNK) StrataGraft Designated as Regenerative Medicine Advanced Therapy by U.S. FDA
July 18, 2017 7:02 AM EDTMallinckrodt plc (NYSE: MNK), today announced that StrataGraft® regenerative skin tissue is among the first products to be designated as a Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Drug Administration (FDA) under the provisions of the 21st Century Cures Act. The company's investigational, tissue-based therapy is currently under evaluation in a Phase 3 trial to assess its efficacy and safety in the promotion of autologous skin regeneration of complex skin defects due to thermal... More
